Found: 25
Select item for more details and to access through your institution.
Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6059, doi. 10.1007/s00432-022-04510-3
- By:
- Publication type:
- Article
From Puppy to Patient: Translational Oncology.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The Evolution of Adjuvant Therapy for Melanoma.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 12, p. 1, doi. 10.1007/s11912-019-0858-3
- By:
- Publication type:
- Article
Evolving Immunotherapy Approaches for Renal Cell Carcinoma.
- Published in:
- Current Oncology Reports, 2016, v. 18, n. 9, p. 1, doi. 10.1007/s11912-016-0542-9
- By:
- Publication type:
- Article
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25859-y
- By:
- Publication type:
- Article
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis.
- Published in:
- European Heart Journal, 2020, v. 41, n. 18, p. 1733, doi. 10.1093/eurheartj/ehaa051
- By:
- Publication type:
- Article
Benefit and toxicity of programmed death‐1 blockade vary by ethnicity in patients with advanced melanoma: an international multicentre observational study*.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 3, p. 401, doi. 10.1111/bjd.21241
- By:
- Publication type:
- Article
Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis.
- Published in:
- European Journal of Endocrinology, 2019, v. 181, n. 3, p. 211, doi. 10.1530/EJE-19-0238
- By:
- Publication type:
- Article
Lessons Learned as a Third-Year Medical Student on a Rotation in Palliative Medicine.
- Published in:
- Journal of Palliative Medicine, 2008, v. 11, n. 5, p. 781, doi. 10.1089/jpm.2008.0022
- By:
- Publication type:
- Article
Systemic immunotherapy for the Treatment of Brain Metast.
- Published in:
- Frontiers in Oncology, 2016, p. 1, doi. 10.3389/fonc.2016.00049
- By:
- Publication type:
- Article
Intralesional Bleomycin for Warts: Patient Satisfaction and Treatment Outcomes.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2015, v. 19, n. 5, p. 470, doi. 10.1177/1203475415576860
- By:
- Publication type:
- Article
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Targeting Molecular Pathways in Intracranial Metastatic Disease.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00099
- By:
- Publication type:
- Article
Stage II desmoplastic melanoma treated with neoadjuvant immunotherapy and Mohs micrographic surgery.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 3, p. e433, doi. 10.1111/jdv.18669
- By:
- Publication type:
- Article
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Neurologic complications of melanoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Temporal Trends and Outcomes Among Patients Admitted for Immune‐Related Adverse Events: A Single‐Center Retrospective Cohort Study from 2011 to 2018.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. 514, doi. 10.1002/onco.13740
- By:
- Publication type:
- Article
Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient Setting.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. 49, doi. 10.1002/onco.13561
- By:
- Publication type:
- Article
Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e398, doi. 10.1634/theoncologist.2018-0883
- By:
- Publication type:
- Article
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistance.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 5, p. 965, doi. 10.1093/neuonc/noad236
- By:
- Publication type:
- Article
Paradox of Hope.
- Published in:
- Journal of Palliative Medicine, 2013, v. 16, n. 10, p. 1307, doi. 10.1089/jpm.2013.0060
- By:
- Publication type:
- Article
Music Lessons.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Melanoma central nervous system metastases: current approaches, challenges, and opportunities.
- Published in:
- Pigment Cell & Melanoma Research, 2016, v. 29, n. 6, p. 627, doi. 10.1111/pcmr.12538
- By:
- Publication type:
- Article
Dose‐escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF‐mutant solid tumors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1904, doi. 10.1002/cncr.34730
- By:
- Publication type:
- Article
Compliance with sentinel lymph node biopsy guidelines for invasive melanomas treated with Mohs micrographic surgery.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 19, p. 3591, doi. 10.1002/cncr.33651
- By:
- Publication type:
- Article